INNERVATE RADIOPHARMACEUTICALS

DEAD

Serial Number

97001206

Owner

INNERVATE RADIOPHARMACEUTICALS LLC

Attorney

Daniel P. Mullarkey

Filing Date

Aug 30, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

INNERVATE RADIOPHARMACEUTICALS Trademark

Serial Number: 97001206

INNERVATE RADIOPHARMACEUTICALS is a trademark filed by INNERVATE RADIOPHARMACEUTICALS LLC on August 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

INNERVATE RADIOPHARMACEUTICALS LLC (3 trademarks)

ENGLEWOOD, NJ 07631

Entity Type: 16

Illumina Radiopharmaceuticals LLC

175 Elm Rd
Englewood, NJ 07631

Entity Type: 16

Legal Representation

Attorney of Record

Daniel P. Mullarkey

3,585 trademarks filed View all →

Correspondence Address

Daniel P. Mullarkey POLSINELLI PC

1401 I STREET, NW, SUITE 800

WASHINGTON, DC 20005

United States

Trademark Details

Filing Date

August 30, 2021

Registration Date

Not Registered

Published for Opposition

February 7, 2023

Goods & Services

Anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments, and cardiovascular treatments; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents and diagnostic media for bacteriological culture, for medical purposes; companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds, all for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Nov 10, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Nov 10, 2025 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 12, 2025 EXRA

SOU EXTENSION 4 GRANTED

Mar 12, 2025 EX4G

SOU EXTENSION 4 FILED

Mar 11, 2025 EXT4

SOU TEAS EXTENSION RECEIVED

Mar 11, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 6, 2024 EXRA

SOU EXTENSION 3 GRANTED

Aug 6, 2024 EX3G

SOU EXTENSION 3 FILED

Aug 6, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Aug 6, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 17, 2024 EXRA

SOU EXTENSION 2 GRANTED

Feb 16, 2024 EX2G

SOU EXTENSION 2 FILED

Feb 16, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Feb 16, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 20, 2023 EXRA

SOU EXTENSION 1 GRANTED

Sep 18, 2023 EX1G

SOU EXTENSION 1 FILED

Sep 18, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Sep 18, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 4, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 7, 2023 NPUB

PUBLISHED FOR OPPOSITION

Feb 7, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 18, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 5, 2023 CNSA

ASSIGNED TO EXAMINER

Dec 29, 2022 DOCK

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 14, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 13, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 13, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 13, 2022 GNRN

NON-FINAL ACTION E-MAILED

Jun 13, 2022 GNRT

NON-FINAL ACTION WRITTEN

Jun 13, 2022 CNRT

ASSIGNED TO EXAMINER

Jun 3, 2022 DOCK

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 12, 2022 ASGN

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 13, 2021 NWOS

NEW APPLICATION ENTERED

Sep 2, 2021 NWAP

Related Trademarks

More from this Owner

INNERVATE RADIOPHARMACEUTICALS

More in Same Class

ALIMDAES ZINC